About 200 reports

  • 3.4.3 Forecast Assumptions and Methods - One-Year Total Prevalent Cases of POUD
  • Risk Factors and Comorbid Conditions Associated with OUD

The Han study provided the data for one-year total prevalence of DSM-IV opioid dependence.

  • Epidemiology
  • Hospital
  • Opioid
  • United States
  • Forecast

Opioid Drugs: Global Markets to 2023 Chapter ## Introduction Study Goals and Objectives Reasons for Doing This Study Scope of Report Information Sources Methodology Geographic Breakdown Analyst’s Credentials BCC Custom Research Related BCC Research Reports Chapter ## Summary and High

  • Opioid
  • Therapy
  • World
  • Market Shares
  • OPIOID ANTAGONISTS
  • Opioid Withdrawal Syndrome and Opioid Use Disorder Patient Populations

" One of the symptoms is opioid withdrawal.

  • Opioid
  • Therapy
  • United States
  • Forecast
  • Omeros Corporation

Global Opioids Drug Market Forecast 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • World

Opioid Tolerance Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 ##.

  • Opioid
  • Therapy
  • APAC
  • World
  • Market Size

GLOBAL NON-OPIOID PAIN TREATMENT MARKET FORECAST 2018-2026 ##.

  • Opioid
  • Therapy
  • World
  • Forecast
  • Market Size

Non-opioid Pain Treatment: Global Markets to 2022 Chapter ##: Introduction ## Study Goals and Objectives ## Reasons for Doing This Study ## Scope of Report ## Information Sources ## Methodology ## Geographic Breakdown ## Analyst’s Credentials ## Related B

  • Analgesic
  • Opioid
  • Therapy
  • World
  • Market Shares

Medical Marijuana and the Opioid Crisis Chapter ## Medical Marijuana and the Opioid Crisis What Are Cannabinoids and How Are They Related to Medical Marijuana?

  • Marijuana
  • Opioid
  • Recreational Activity
  • United States
  • Market Size

Global Non-Opioid Pain Relief Device Market: Focus on Application, Technology, End-User, Competitive Landscape – Analysis and Forecast, 2018-2029 ## Market Overview ##. ## Pain Management Overview ##. ## Pain Management by Usage of Opioid Drugs ##. ## Pain Management by

  • Opioid
  • Pain Relief
  • Therapy
  • World
  • Forecast

EUROPE OPIOIDS DRUG MARKET FORECAST 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • Europe
  • Forecast

ASIA PACIFIC OPIOIDS DRUG MARKET FORECAST 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • APAC
  • Forecast

NORTH AMERICA OPIOIDS DRUG MARKET FORECAST 2019-2027 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • North America

Opioids Market Size, Share & Trends Analysis Report By Product, By Application, By Region And Segment Forecasts, 2019 - 2026 Chapter ## Methodology and Scope ##. ##.

  • Opioid
  • Therapy
  • United States
  • Forecast
  • Market Size
  • A COMPARISON OF OPIOID AND NON-OPIOID DRUGS
  • PRIMARY ROUTES OF OPIOID ABUSE

ZACHAROFF, THIS COULD BE ONE OF THE PRIMARY REASONS FOR THE OPIOID EPIDEMIC. ##. ##. ##. ##.

  • Opioid
  • North America
  • United States
  • Eli Lilly & Co.
  • Grunenthal GmbH

Non-opioid Pain Patch Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024 ##.

  • Opioid
  • Pharmaceutical
  • Therapy
  • World
  • Forecast

2019 Future of Opioid/ Opium Addiction R& D Pipeline Drugs and Companies- Analysis of Pipeline Compounds, Phases, Mechanism of Action, Clinical Trials and Developments ##.

  • Opioid
  • Therapy
  • ADVICE FOR THE TECHNOLOGY BUYER
  • Data Access and Sharing

IDC ANALYZE THE FUTURE IDC PERSPECTIVE Adelaide O' Brien EXECUTIVE SNAPSHOT FIGURE ## Addiction Prevention and Monitoring: Leveraging DX to Tackle the Opioid Epidemic in Kentucky Executive Snapshot: Addiction Prevention and Monitoring - Leveraging DX to Tackle the

  • Advanced IT
  • Healthcare
  • Opioid
  • Therapy
  • United States

Global Market Study on Opioids: Widespread Usage in Treatment of Cancer to Drive the Growth of Opioids Market During the Forecast Period ##.

  • Opioid
  • Therapy
  • APAC
  • World
  • Market Size
  • JUN 22, 2018: ANALYSIS OF INSURANCE COVERAGE FOR BACK PAIN SHOWS MISSED OPPORTUNITIES TO PRESCRIBE NON-OPIOID MEDICATIONS
  • JUN 19, 2018: METHADONE AND BUPRENORPHINE REDUCE RISK OF DEATH AFTER OPIOID OVERDOSE

" Opioid addiction has emerged as one of the most critical public health issues, said Dr.

  • Opioid
  • Therapy
  • United States
  • Lightlake Therapeutics Inc.
  • Opiant Pharmaceuticals, Inc.

One of the major determinants is the growing geriatric population with clinically demonstrated susceptibility to terminal conditions, such as rheumatoid arthritis, is positively impacting this vertical.

  • Opioid
  • Therapy
  • North America
  • United States
  • Forecast

Chapter ## – Executive Summary The report commences with an executive summary of the oxycodone market report, which includes the summary of key findings and key statistics.

  • Opioid
  • North America
  • World
  • Forecast
  • Market Size
  • NON-GOVERNMENT INSTITUTIONS INITIATIVES
  • 9.4 INCREASED PRODUCTION AND TRAFFICKING OF ILLEGAL DRUGS

The overdose of opioids results in adverse and serious health conditions.

  • Opioid
  • World
  • Forecast
  • Alere Inc.
  • Danaher Corporation
  • OPIOID PRESCRIPTIONS
  • ADVANCES IN OPIOID RECEPTOR RESEARCH

BUNAVAIL CONTAINS BUPRENORPHINE HCL, A MU--OPIOID RECEPTOR PARTIAL AGONIST AND A KAPPA--OPIOID RECEPTOR ANTAGONIST, AND NALOXONE HCL DIHYDRATE, AN OPIOID RECEPTOR ANTAGONIST, AT A RATIO OF ~##:## (RATIO OF FREE BASES).

  • Opioid
  • Actavis plc
  • Bedrocan Canada Inc.
  • Insys Therapeutics, Inc.
  • Medical Marijuana, Inc.
  • Opioids
  • Opioids

You can easily book an appointment with one online.

  • Opioid
  • Market Size
  • BioDelivery Sciences International, Inc.
  • ProStrakan Group plc
  • Teva Pharmaceuticals Ltd.
  • Opioid-Induced Constipation (OIC) - Drug Profiles
  • Opioid-Induced Constipation (OIC) - Product Development Milestones

The molecules developed by Companies in Phase III, Phase II and Phase I stages are ##, ## and ## respectively.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • United States
  • Product Initiative
  • Revenue of Key Products in Opioid Category 2016- 2018
  • Opioids Market: Revenue Share (% ), by Country, Europe, 2018

Opioids have been regarded as one of the most effective drugs for the treatment of pain.

  • Opioid
  • North America
  • United States
  • World
  • Market Size
  • Opioid-Induced Constipation (OIC) - Product Development Milestones
  • Opioid-Induced Constipation (OIC) - Therapeutics Assessment

The molecules developed by Companies in Pre-Registration, Phase III and Phase II stages are ##, ## and ## respectively.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • United States
  • Product Initiative
  • VACCINE FOR OPIOID ADDICTION - DRUG PROFILE
  • Opium (Opioid) Addiction - Therapeutics Assessment

Opium (Opioid) Addiction - Overview Opium (Opioid) Addiction - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPIUM (OPIOID) ADDICTION, H## 2018 PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPIUM (OPIOID) ADDICTION, H## 2018 Pre-Regi

  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Discontinued Products
  • Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) - Product Development Milestones

It binds to opioid receptor like ## (ORL-##, NOC-##) receptor.

  • Opioid
  • Therapy
  • United States
  • World
  • Product Initiative

ALKS 5461

8770 10000 7800

ALKS ## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## ALKS ## : Depression LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of ALKS ## for depression ## Figure ##: Datamonitor Healthcare’s drug assessment summary of ALKS ## for depressio

  • Opioid
  • Therapy
  • United States